Andrew Cittadine
Chief Operating Officer · Monopar Therapeutics
Individual
- 2024
- Oct 2, 2026
- 6
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Cittadine files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chandler Robinson - $2.56M in MNPR purchases and sales in the last 12 months
- Kim R. Tsuchimoto - $911K in MNPR purchases and sales in the last 12 months
- Raymond Anderson - $703K in MNPR purchases and sales in the last 12 months
- Christopher M. Starr - $659K in MNPR purchases and sales in the last 12 months
- Patrice Rioux - $111 in MNPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Cittadine?
Andrew Cittadine is a corporate insider, tracked as Chief Operating Officer of Monopar Therapeutics (MNPR). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew Cittadine submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
